Part 1 of 3: The Upcoming Flu Season

Flu Vaccine Report

The 2022–2023 U.S. flu season peaked earlier than in past years, with confirmed influenza-like illnesses and hospitalizations in October 2022. Over 26 million influenza-like illnesses and 290,000 hospitalizations were reported in the previous flu season. Following the Southern Hemisphere’s lead, the U.S. prepares for a potentially difficult 2023-2024 flu season.

Download the first of three preview reports for early insights into the upcoming flu season, including:

  • An estimated 166.5 million flu vaccine doses will be manufactured for the upcoming 2023–2024 flu season.
  • Earlier flu vaccination is recommended for children in the U.S. receiving two doses of the influenza vaccine.
  • In the 2023-2024 Australia flu season, 80% of those admitted to the hospital with flu-related symptoms have been children.

Free Download For HIDA Members


Don't Miss The Webinar: Preparing For The 2023-2024 Flu Season

Join Dr. Litjen (L.J.) Tan, PhD, Chief Policy and Partnerships Officer of and Co-Chair of the National Adult and Influenza Immunization Summit, to find out how you can help your provider customers protect their patients from the flu. Learn more and register here.

Related Content

Market Insights
Market Report
Vaccine Market Report
Emergency Preparedness
HIDA Webinar
Preparing For The 2022-2023 Flu Season
Pandemic Preparedness
Optimizing Use Of Medical Supplies During The COVID-19 Vaccination Effort
Vaccines, COVID-19
Vaccine Comparison
Comparison Of Leading COVID-19 Vaccines For U.S. Distribution


Chandler Mobley

Chandler Mobley, MPH
Manager, Research & Market Insights